Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Sep 24;9(40):41555-41564.
doi: 10.1021/acsomega.4c05292. eCollection 2024 Oct 8.

Polymorphism in oxyresveratrol studied by 3D ED

Affiliations

Polymorphism in oxyresveratrol studied by 3D ED

Elena Husanu et al. ACS Omega. .

Abstract

The polymorphism of oxyresveratrol, a natural extract widely used in traditional Asian medicine, was investigated by means of the most recent structure characterization techniques. A previously unknown anhydrate oxyresveratrol crystal structure was identified for the first time from a submicrometric polyphasic mixture using 3D electron diffraction (3D ED). Additionally, a new polymorph of the dihydrate form of oxyresveratrol was also discovered and structurally studied. Detailed thermal and calorimetry studies revealed their thermal behavior and dehydration path. DFT calculations were also employed to investigate the stability of the rotational conformers involved in the hydrated phases (in both new and already known phases). This research exemplifies how 3D ED combined with cryo-plunging and routine solid-state analysis can elucidate the polymorphism scenario of a nanocrystalline natural compound.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing financial interest.

Figures

Figure 1
Figure 1
Molecular structure of oxyresveratrol (ORV). The structure is shown with the atomic labeling adopted in the paper.
Figure 2
Figure 2
Reconstruction of the reciprocal space of A-ORV view along the a* reciprocal direction. The arrows highlight the extinctions corresponding to the reflection condition h0l:l = 2n characteristic to a c glide plane perpendicular to b. In the box at the top left is displayed a HAADF-STEM image of typical crystals of A-ORV used for 3D ED data collection.
Figure 3
Figure 3
Crystal structure of A-ORV view along a, b axes and along [401] direction. In the view along b, the staggered configuration of the two chain systems is clearly visible. If the structure is viewed along [401] the interpenetration of the two chain systems can be seen. In the figure three chain layers running along [401] are displayed (indicated by light blue arrows) alternated with two layers of chains running along [−401]. Color code: brown C, red O, white H.
Figure 4
Figure 4
Reconstruction of the reciprocal space of H-ORV view along the a* reciprocal direction. The arrows highlight the extinctions corresponding to reflection condition h0l:l = 2n. In the box at the top left is displayed a HAADF-STEM image of typical crystals of H-ORV used for 3D ED data collection.
Figure 5
Figure 5
Profile fit from Rietveld refinement on PXRD data of H-ORV. The shown range is limited to 2θ values of 5–70° for clarity, whereas the refinement was carried out in the range 3–90°. The refinement converged to Rp = 8.02% and wRp = 11.68%.
Figure 6
Figure 6
(Left and center) Crystal structure of H-ORV view along a, b without hydrogens. (Right) In the b projection, one layer of molecule chains is highlighted by orange lines. The chains are indicated by orange arrows. Color code: brown C, red O, light blue O of the water molecules.
Figure 7
Figure 7
(a) Interconversion equilibrium between ORV forms 1 and 2. The related thermodynamic equilibrium constant is K = 0.46. (b) The plot represents the molecular energy as a function of the dihedral angle involved in the interconversion equilibrium. ΔE = 1.94 kJ mol–1 and Ea = 22.72 kJ mol–1. The calculations were conducted by using a DFT theory level with a B3LYP functional and a 6-311+(3d, p) basis set.

References

    1. Cruz-Cabeza A. J.; Bernstein J. Conformational Polymorphism. Chem. Rev. 2014, 114 (4), 2170–2191. 10.1021/cr400249d. - DOI - PubMed
    1. Thakuria R.; Thakur T. S.. 5.13 - Crystal Polymorphism in Pharmaceutical Science. In Comprehensive Supramolecular Chemistry II; Atwood J. L., Ed.; Oxford: Elsevier, 2017; pp 283–30910.1016/B978-0-12-409547-2.12570-3. - DOI
    1. Munroe Á.; Rasmuson Å. C.; Hodnett B. K.; Croker D. M. Relative Stabilities of the Five Polymorphs of Sulfathiazole. Cryst. Growth Des. 2012, 12 (6), 2825–2835. 10.1021/cg201641g. - DOI
    1. Moondra S.; Maheshwari R.; Taneja N.; Tekade M.; Tekadle R. K.. Chapter 6 - Bulk Level Properties and Its Role in Formulation Development and Processing. In Dosage Form Design Parameters; Tekade R. K., Ed.; Academic Press, 2018; pp 221–256.10.1016/B978-0-12-814421-3.00006-3 - DOI
    1. Tandon R.; Tandon N.; Thapar R. K.. Patenting of Polymorphs. Pharmaceutical Patent Analyst. Newlands Press Ltd; March 1, 2018; pp 59–63.10.4155/ppa-2017-0039 - DOI - PubMed